Patterns of inflammatory responses following rechallenge of skin late-phase allergic reaction sites

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 1, 1998, Pages 94-98

  Zweiman, Burton ^a,c   Von Allmen, Carolyn ^a   Schwartz, Lawrence B ^b   Atkins, Paul C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Allergic; Late phase reactions; Rechallenge

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; IMMUNOGLOBULIN E; LACTOFERRIN; POLLEN ANTIGEN; TRYPTASE;

ALLERGIC REACTION; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; DESENSITIZATION; HISTAMINE BLOOD LEVEL; HUMAN; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROVOCATION TEST; SKIN TEST;

CHYMASES; HISTAMINE; HYPERSENSITIVITY, IMMEDIATE; POACEAE; SERINE ENDOPEPTIDASES; SKIN TESTS; TIME FACTORS; TRYPTASES;

EID: 0031843379     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70059-4     Document Type: Article

References (13)

1. Connell JT. Quantitative intranasal pollen challenges. III. The priming effect in allergy rhinitis. J Allergy 1969;43:33-6.
2. Iliopoulos O, Proud D, Adkinson NF Jr, Norman PS, Kagey-Sobotka A, Lichtenstein LM, et al. Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 1990;86:851-61.
3. Wachs M, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio R. Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol 1989;84:492-501.
4. Shaikh W, Umemoto L, Poothullil J, Hargreave FE, Dolovich J. Relative refractory state for late cutaneous allergic responses. J Allergy Clin Immunol 1977;60:242-6.
5. Andersson M, Pipkorn U. Immediate and late phase allergic cutaneous reactions are not inducers of unspecific or specific local hyperreactivity. Allergy 1988;43:597-602.
6. Shalit M, Schwartz LB, von Allmen C, Valenzano M, Fleekop P, Atkins PC, et al. Histamine and tryptase release in the skin after prolonged in vivo antigen exposure in humans. J Immunol 1988;141:821-6.
7. Shalit M, Schwartz LB, von Allmen C, Atkins PC, Lavker RM, Zweiman B. Release of histamine and tryptase during continuous and interrupted cutaneous challenge with allergen in humans. J Allergy Clin Immunol 1990;86:117-25.
8. Atkins PC, Zweiman B, Moskovitz AR, von Allmen C, Ciliberti M. Cellular inflammatory responses and mediator release during early developing late phase allergic cutaneous inflammatory responses: effects of cetirizine. J Allergy Clin Immunol 1997;99:806-11.
9. Schwartz LB, Bradford TR, Rouse C. Development of a new, more sensitive immunoassay for human tryptase. Use in systemic anaphylaxis. J Clin Immunol 1994;14:190-204.
10. Zweiman B, Kucich U, Shalit M, von Allmen C, Moskovitz A, Weinbaum G, et al. Release of lactoferrin and elastase in human allergic skin reactions. J Immunol 1990;144:3953-60.
11. Zweiman B, Kaplan AP, Joseph K, Moskovitz AR. Cytokine levels and inflammatory responses in developing allergic late phase reactions in the skin. J Allergy Clin Immunol 1997;100:104-9.
12. Fleekop PD, Atkins PC, Von Allmen C, Valenzano M, Shalit M, Zweiman B. Cellular inflammatory response in human allergic skin reactions. J Allergy Clin Immunol 1987;80:140-6.
13. Irani AM, Huang C, Xia HZ, Kepley C, Nafie A, Fouda ED, et al. Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol 1998;101:354-62.